← Home
💊 Pharmaceuticals — Top Stocks by Market Cap
1,859 companies · updated every 5–20 min
Pharmaceutical and biotech stocks on this page cover drug manufacturers and related healthcare innovators, ranked by market capitalisation. Large-cap pharma often mixes defensive cash-flow businesses with pipeline-driven growth names. Scan the sector leaders here, then open a company page for deeper market data.
We currently track 1,859 companies in Pharmaceuticals worldwide. Johnson & Johnson leads with a market cap of $642.79B, followed by AbbVie Inc. ($465.02B) and Roche Holding AG ($333.39B). Combined, the top 100 companies on this page are worth $5.66T.
| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 1 | ₩1515000.00 | -2.19% | +1.52% | ₩70.13T | 6.66K shrs ₩10.09B | ||
| 2 | ₩185400.00 | +4.51% | +2.26% | ₩42.52T | 120.8K shrs ₩22.4B | ||
| 3 | ₩296500.00 | -4.97% | -5.38% | ₩15.87T | — | ||
| 4 | ¥6974.00 | -0.36% | -1.07% | ¥11.48T | 488.2K shrs ¥3.4B | ||
| 5 | ¥5767.00 | +0.40% | +3.33% | ¥9.21T | 580.5K shrs ¥3.35B | ||
| 6 | ¥11445.00 | +0.53% | +6.67% | ¥6.01T | 191.7K shrs ¥2.19B | ||
| 7 | ¥2838.50 | -1.77% | +4.53% | ¥5.17T | 940.8K shrs ¥2.67B | ||
| 8 | ₹1977.20 | +0.19% | — | ₹4.74T | 135.53K shrs ₹267.98M | ||
| 9 | ₹1976.70 | +0.15% | -0.10% | ₹4.74T | 4.58M shrs ₹9.05B | ||
| 10 | ¥2226.50 | -0.31% | -0.93% | ¥3.99T | 1.29M shrs ¥2.88B | ||
| 11 | ¥2902.50 | +0.28% | -1.35% | ¥2.47T | 2.13M shrs ¥6.18B | ||
| 12 | ₹7425.00 | +0.15% | -2.99% | ₹1.97T | 410.38K shrs ₹3.05B | ||
| 13 | ₹7420.45 | +0.06% | -3.57% | ₹1.97T | 21.99K shrs ₹163.16M | ||
| 14 | ₹4898.30 | -2.41% | +2.81% | ₹1.86T | 549.15K shrs ₹2.69B | ||
| 15 | ₹4899.30 | -2.35% | — | ₹1.66T | 42.68K shrs ₹209.1M | ||
| 16 | ₹1444.60 | +2.50% | +1.65% | ₹1.17T | 1.62M shrs ₹2.34B | ||
| 17 | ₹1444.65 | +2.47% | — | ₹1.17T | 80.89K shrs ₹116.85M | ||
| 18 | ₹1099.60 | -0.76% | +2.26% | ₹1.1T | 15.87K shrs ₹17.46M | ||
| 19 | ₹1099.20 | -0.81% | -0.27% | ₹1.1T | 748.14K shrs ₹822.36M | ||
| 20 | ₹2395.80 | -0.59% | +1.68% | ₹1.1T | 607.76K shrs ₹1.46B | ||
| 21 | ₹2394.70 | -0.63% | — | ₹1.09T | 4.93K shrs ₹11.8M | ||
| 22 | ₹2618.15 | +2.63% | -1.85% | ₹1.08T | 23.69K shrs ₹62.01M | ||
| 23 | ₹2617.90 | +2.60% | -1.51% | ₹1.08T | 610.06K shrs ₹1.6B | ||
| 24 | ₹1758.90 | +2.66% | +0.83% | ₹950.25B | 4.41M shrs ₹7.75B | ||
| 25 | ₹1758.00 | +2.55% | +4.00% | ₹949.76B | 235.09K shrs ₹413.28M | ||
| 26 | ₹1135.60 | -1.32% | +2.97% | ₹945.95B | 2.16M shrs ₹2.45B | ||
| 27 | ₹1135.65 | -1.33% | — | ₹945.51B | 103.85K shrs ₹117.93M | ||
| 28 | ₹1550.50 | +0.11% | — | ₹901.91B | 10.15K shrs ₹15.74M | ||
| 29 |  Johnson & Johnson JNJ🇺🇸USD | $266.73 | +0.29% | +6.23% | $642.79B | 10.39M shrs $2.77B | |
| 30 |  AbbVie Inc. ABBV🇺🇸USD | $263.20 | +2.45% | +6.94% | $465.02B | 5.19M shrs $1.37B | |
| 31 | NT$1115.00 | -6.69% | +24.20% | NT$460.62B | 2.79M shrs NT$3.11B | ||
| 32 | HK$57.60 | +0.96% | +5.28% | HK$382.3B | 1.62M shrs HK$93.27M | ||
| 33 | ¥263.18 | -3.95% | +14.82% | ¥354.97B | 3.59M shrs ¥944.9M | ||
| 34 | ¥53.29 | -0.58% | +9.80% | ¥353.7B | 47.98M shrs ¥2.56B | ||
| 35 |  Novartis AG NVS🇺🇸USD | $159.85 | +2.40% | +0.50% | $303.83B | 1.63M shrs $260.07M | |
| 36 | Fr 373.60 | +2.36% | +0.97% | Fr 297.67B | 25.16K shrs Fr 9.4M | ||
| 37 | Fr 367.90 | +2.17% | +1.11% | Fr 293.13B | 1.04M shrs Fr 381.33M | ||
| 38 | HK$195.30 | -2.20% | +5.71% | HK$263.41B | 3.31M shrs HK$646.37M | ||
| 39 |  Novartis AG NOVN.SW🇨🇭CHF | Fr 130.40 | +1.46% | +1.28% | Fr 247.85B | 2.56M shrs Fr 333.59M | |
| 40 |  Amgen Inc. AMGN🇺🇸USD | $393.10 | +4.48% | +4.13% | $212.16B | 3.19M shrs $1.26B | |
| 41 |  AstraZeneca PLC AZN.L🇬🇧GBp | £1.29 | +0.40% | +1.94% | £200.68B | 69.34K shrs £8.97M | |
| 42 | HK$32.32 | +0.06% | +0.14% | HK$195.95B | 5.9M shrs HK$190.64M | ||
| 43 | $134.32 | +2.91% | +0.74% | $166.77B | 6.94M shrs $932.73M | ||
| 44 | kr 466.80 | +0.60% | +0.39% | kr 162.77B | 318.87K shrs kr 148.85M | ||
| 45 | HK$38.58 | -0.21% | +12.56% | HK$158.42B | 13.55M shrs HK$522.68M | ||
| 46 | HK$89.90 | +0.62% | +5.64% | HK$156.51B | 7.82M shrs HK$702.93M | ||
| 47 | $63.60 | +1.66% | +1.64% | $129.88B | 8.43M shrs $536.12M | ||
| 48 | ¥307.01 | -1.99% | +26.73% | ¥126.76B | 1.21M shrs ¥371.77M | ||
| 49 | $490.39 | +2.38% | +6.32% | $124.46B | 1.7M shrs $833.52M | ||
| 50 | HK$508.50 | -0.97% | +11.16% | HK$121.54B | 338.64K shrs HK$172.2M | ||
| 51 | HK$37.96 | +0.48% | -3.07% | HK$121.07B | 4.92M shrs HK$186.66M | ||
| 52 |  Genmab A/S GMAB.CO🇩🇰DKK | kr 1879.50 | -1.65% | +5.36% | kr 115.39B | 9.34K shrs kr 17.55M | |
| 53 | ₪0.96 | +0.89% | +2.45% | ₪111.61B | 831.77K shrs ₪79.73M | ||
| 54 | HK$8.49 | +2.29% | +1.75% | HK$96.83B | 71.72M shrs HK$608.93M | ||
| 55 | €79.38 | +2.04% | -0.57% | €95.01B | 1.94M shrs €154.24M | ||
| 56 | ¥51.43 | +0.61% | -1.15% | ¥91.76B | 6.66M shrs ¥342.44M | ||
| 57 | HK$5.09 | +0.00% | -0.90% | HK$90.47B | 36.61M shrs HK$186.35M | ||
| 58 | ¥29.19 | -2.24% | +0.77% | ¥89.71B | 29.47M shrs ¥860.31M | ||
| 59 |  Akeso, Inc. 9926.HK🇭🇰HKD | HK$96.00 | -2.64% | +6.15% | HK$88.43B | 4.81M shrs HK$462.01M | |
| 60 | ¥136.01 | +1.30% | +1.29% | ¥82.06B | 7.5M shrs ¥1.02B | ||
| 61 | £0.20 | +3.47% | -1.40% | £81.27B | 100K shrs £2.03M | ||
| 62 | $695.18 | +4.20% | +1.08% | $72.88B | 878.16K shrs $610.48M | ||
| 63 | $17.52 | +0.46% | +0.69% | $55.95B | 3.76M shrs $65.81M | ||
| 64 | $872.23 | -1.87% | +6.57% | $54.24B | 293.94K shrs $256.39M | ||
| 65 | €772.00 | -2.25% | -2.39% | €48.01B | 84.93K shrs €65.57M | ||
| 66 | €47.03 | -0.42% | — | €46.2B | 1.39M shrs €65.45M | ||
| 67 |  Haleon plc HLN🇺🇸USD | $10.27 | +3.32% | +5.03% | $45.23B | 16.61M shrs $170.62M | |
| 68 | Fr 176.95 | +1.93% | +2.03% | Fr 41.26B | 357.87K shrs Fr 63.33M | ||
| 69 | $183.86 | -2.24% | +10.62% | $39.09B | 2.33M shrs $429.04M | ||
| 70 | $288.41 | +3.60% | +4.68% | $38.51B | 1.37M shrs $395.57M | ||
| 71 | $31.67 | +1.90% | +0.69% | $36.88B | 4.44M shrs $140.66M | ||
| 72 | $59.97 | +2.11% | +0.78% | $34.53B | 3.03M shrs $181.47M | ||
| 73 | $330.46 | +1.40% | +5.29% | $34.29B | 255.58K shrs $84.46M | ||
| 74 |  Haleon plc HLN.L🇬🇧GBp | £0.04 | +2.89% | +5.03% | £33.55B | 1.62K shrs £6.17K | |
| 75 |  Biogen Inc. BIIB🇺🇸USD | $205.61 | +2.73% | +6.36% | $30.36B | 1.59M shrs $326.26M | |
| 76 | Fr 65.04 | +2.39% | +1.73% | Fr 28.14B | 478.6K shrs Fr 31.13M | ||
| 77 | $523.63 | -0.82% | +0.52% | $26.08B | 359.05K shrs $188.01M | ||
| 78 | $129.93 | +9.30% | +9.01% | $25.96B | 5.84M shrs $758.65M | ||
| 79 | $33.84 | -2.53% | +8.76% | $24.34B | 4.4M shrs $148.9M | ||
| 80 |  BioNTech SE BNTX🇺🇸USD | $92.45 | +1.49% | +3.64% | $23.38B | 652.73K shrs $60.34M | |
| 81 | $104.13 | -0.57% | +4.75% | $22.57B | 1.95M shrs $202.57M | ||
| 82 |  Moderna, Inc. MRNA🇺🇸USD | $55.80 | +0.31% | +18.85% | $22.14B | 5.55M shrs $309.86M | |
| 83 |  Viatris Inc. VTRS🇺🇸USD | $17.86 | +1.28% | +2.73% | $20.8B | 8.64M shrs $154.3M | |
| 84 | $182.83 | +3.64% | +3.92% | $18.38B | 1.33M shrs $243.73M | ||
| 85 |  Genmab A/S GMAB🇺🇸USD | $29.00 | +0.69% | +6.55% | $17.8B | 2.21M shrs $64.05M | |
| 86 | $85.55 | +1.70% | +8.58% | $16.76B | 2.13M shrs $181.87M | ||
| 87 | $254.44 | +0.40% | +12.24% | $16.69B | 563.4K shrs $143.35M | ||
| 88 | $256.92 | +0.58% | +3.15% | $16.14B | 945.15K shrs $242.83M | ||
| 89 |  Exelixis, Inc. EXEL🇺🇸USD | $56.51 | +1.25% | +5.10% | $14.2B | 2.48M shrs $139.93M | |
| 90 | $25.52 | +0.43% | +3.93% | $12.75B | 3.64M shrs $92.89M | ||
| 91 | $538.80 | -2.26% | +0.19% | $12.42B | 211.13K shrs $113.76M | ||
| 92 | $85.78 | +0.29% | +0.68% | $12.08B | 1.69M shrs $145.35M | ||
| 93 | $234.20 | -1.75% | -0.54% | $12.05B | 392.52K shrs $91.93M | ||
| 94 | $62.07 | +2.99% | +2.34% | $12B | 1.9M shrs $118.05M | ||
| 95 | €80.75 | +1.51% | +2.76% | €11.37B | 162.7K shrs €13.14M | ||
| 96 | €80.50 | +1.64% | +2.32% | €11.34B | 6.09K shrs €490.16K | ||
| 97 | $72.07 | +0.63% | +26.20% | $11.23B | 6.72M shrs $484.52M | ||
| 98 | $79.45 | -1.45% | +6.56% | $10.79B | 1.37M shrs $108.9M | ||
| 99 | $364.23 | +3.53% | +9.22% | $10.74B | 402.3K shrs $146.53M | ||
| 100 | €51.30 | -0.29% | — | €10.44B | 193.46K shrs €9.92M |
Browse by Country
Europe
Asia